Time to let the cat out of the bag!

There is some exciting business news: RDVO has been formally acquired by Cambridge BioMarketing Group, LLC.

CB is an integrated healthcare communications agency located in Cambridge. They are one of the top independent agencies in the Northeast, working with leading companies like Genzyme, BiogenIdec, Novartis, and Millennium Pharmaceuticals. The entire RDVO team will be merging into their group and I’ll be leading their digital strategy and services division.

The healthcare industry is in the midst of technology revolution, and we will be working on innovative new programs for personalized medicine, platforms for patient and physician communications, medical software and devices, online clinical research, and strategies for digital marketing, media, and analytics.

While our focus moving forward will be on healthcare, we will continue to support other industries and now have even more talented UX designers, strategists, and developers to rely on. This acquisition also allows to offer new services to clients that we haven’t been able to provide in the past.

Much more on this great news to follow in the coming weeks. In the meantime, please check out Cambridge BioMarketing’s website to learn more about more team, and be sure to follow us on Twitter!

Related posts:

• Healthcare Marketing and Government Reforms
• Job Hunting Advice for Marketing Majors
• Some Updates

This entry was posted on Thursday, October 8th, 2009 at 6:48 pm and is filed under RDVO, Work. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.